Cite
HARVARD Citation
Kang, L. et al. (2021). CD38‐Targeted Theranostics of Lymphoma with 89Zr/177Lu‐Labeled Daratumumab. Advanced science. 8 (10), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kang, L. et al. (2021). CD38‐Targeted Theranostics of Lymphoma with 89Zr/177Lu‐Labeled Daratumumab. Advanced science. 8 (10), p. n/a. [Online].